Why Moderna Stock Is Rising Today
The stock of top coronavirus vaccine maker Moderna (NASDAQ: MRNA) was doing well on Wednesday. In mid-afternoon trading it was outpacing the S&P 500 index with a 1.3% rise; it seems an article published in The New York Times earlier in the day helped bring some investors back into the stock.
Citing several recent research studies, the Times wrote that Moderna's mRNA-1273 appears to provide more durable long-term protection against the coronavirus than Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) Comirnaty.
Image source: Getty Images.
Source Fool.com


